See also this year's filing and all EDGAR filings for this company.
PDF Report 0001157601_2026_Madrigal_Pharmaceuticals_INC.pdf
Logs
Graph
Absolute values for 0001157601, Madrigal Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 1,245,770,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 7,381,000 |
| 2 | PropertyPlantAndEquipmentNet | 1,499,000 |
| 3 | remainder_Assets | 4,939,000 |
| 4 | LiabilitiesCurrent | 310,288,000 |
| 5 | LiabilitiesNoncurrent | 346,612,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 6,117,189 |
| 8 | SellingGeneralAndAdministrativeExpense | 2,705,899,635 |
| 9 | ResearchAndDevelopmentExpense | 395,374,207 |
| 10 | remainder_Expenses | 68,443,183 |
| 11 | remainder_Revenues | 4,848,781,833 |
| 12 | remainder_NetIncome | 31,753,821 |
| 13 | remainder_ComprehensiveNetIncome | 431,775 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 1,259,589,000 |
| 1 | Liabilities | 656,900,000 |
| 2 | Expenses | 3,175,834,214 |
| 3 | Revenues | 4,848,781,833 |
| 4 | StockholdersEquity | 602,689,000 |
| 5 | NetIncome | 1,704,701,440 |
| 6 | ComprehensiveNetIncome | 1,704,917,328 |
| 7 | BaseVar | 4,986,645,322 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.15 |
| 9 | EconomicCapitalRatio | 3.79 |
Edgar->Model Mapping
Feature Distribution
Change over Time
